Stem cell engraftment strategies

P. J. Quesenberry, F. M. Stewart, P. Becker, Lionel D'Hondt, A. Frimberger, J. F. Lambert, G. A. Colvin, C. Miller, C. Heyes, Mehrdad Abedi, M. Dooner, J. Carlson, J. Reilly, C. McAuliffe, K. Stencel, K. Ballen, R. Emmons, P. Doyle, S. Zhong, H. WangH. Habibian

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The donor stem cell phenotype and host microenvironment determine the outcome of a stem cell transplant. In a series of transplant studies in syngeneic male to female or congenic Ly5.1/Ly5.2 models in which hosts have received no or minimal irradiation (100 cGy), evidence overwhelmingly supports the concept that syngeneic engraftment is determined by stem cell competition. These approaches can be extended to H-2 mismatched allogeneic mouse combination when antigen pre-exposure and CD40-CD40 ligand antibody blockage are employed. A human trial in patients with resistant neoplasia infusing pheresed blood with 108 CD3 cells/kg showed that tumor responses and complete chimerism occur with very low levels of CD34+ cells/kg and that the extent of previous treatment is a critical factor in determining chimerism. A major feature of transplants is the phenotype of the donor stem cell. This phenotype shows dramatic reversible plasticity involving differentiation, adhesion protein expression, and engraftment with cytokine-induced cell-cycle transit. Homing is probably also plastic. Marked fluctuations in engraftment capacity are also seen at different points in marrow circadian rhythm.

Original languageEnglish (US)
Pages (from-to)54-62
Number of pages9
JournalAnnals of the New York Academy of Sciences
Volume938
StatePublished - 2001
Externally publishedYes

Fingerprint

Stem cells
Transplants
Stem Cells
Chimerism
Phenotype
Tissue Donors
CD40 Ligand
Circadian Rhythm
Plastics
Plasticity
Tumors
Neoplasms
Cell Cycle
Blood
Adhesion
Bone Marrow
Cells
Irradiation
Cytokines
Antigens

Keywords

  • Circadian rhythm
  • Engraftment
  • Myeloablation
  • Plasticity
  • Stem cell

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Quesenberry, P. J., Stewart, F. M., Becker, P., D'Hondt, L., Frimberger, A., Lambert, J. F., ... Habibian, H. (2001). Stem cell engraftment strategies. Annals of the New York Academy of Sciences, 938, 54-62.

Stem cell engraftment strategies. / Quesenberry, P. J.; Stewart, F. M.; Becker, P.; D'Hondt, Lionel; Frimberger, A.; Lambert, J. F.; Colvin, G. A.; Miller, C.; Heyes, C.; Abedi, Mehrdad; Dooner, M.; Carlson, J.; Reilly, J.; McAuliffe, C.; Stencel, K.; Ballen, K.; Emmons, R.; Doyle, P.; Zhong, S.; Wang, H.; Habibian, H.

In: Annals of the New York Academy of Sciences, Vol. 938, 2001, p. 54-62.

Research output: Contribution to journalArticle

Quesenberry, PJ, Stewart, FM, Becker, P, D'Hondt, L, Frimberger, A, Lambert, JF, Colvin, GA, Miller, C, Heyes, C, Abedi, M, Dooner, M, Carlson, J, Reilly, J, McAuliffe, C, Stencel, K, Ballen, K, Emmons, R, Doyle, P, Zhong, S, Wang, H & Habibian, H 2001, 'Stem cell engraftment strategies', Annals of the New York Academy of Sciences, vol. 938, pp. 54-62.
Quesenberry PJ, Stewart FM, Becker P, D'Hondt L, Frimberger A, Lambert JF et al. Stem cell engraftment strategies. Annals of the New York Academy of Sciences. 2001;938:54-62.
Quesenberry, P. J. ; Stewart, F. M. ; Becker, P. ; D'Hondt, Lionel ; Frimberger, A. ; Lambert, J. F. ; Colvin, G. A. ; Miller, C. ; Heyes, C. ; Abedi, Mehrdad ; Dooner, M. ; Carlson, J. ; Reilly, J. ; McAuliffe, C. ; Stencel, K. ; Ballen, K. ; Emmons, R. ; Doyle, P. ; Zhong, S. ; Wang, H. ; Habibian, H. / Stem cell engraftment strategies. In: Annals of the New York Academy of Sciences. 2001 ; Vol. 938. pp. 54-62.
@article{40ef5cad594442acac6e29c4cc9b8ccb,
title = "Stem cell engraftment strategies",
abstract = "The donor stem cell phenotype and host microenvironment determine the outcome of a stem cell transplant. In a series of transplant studies in syngeneic male to female or congenic Ly5.1/Ly5.2 models in which hosts have received no or minimal irradiation (100 cGy), evidence overwhelmingly supports the concept that syngeneic engraftment is determined by stem cell competition. These approaches can be extended to H-2 mismatched allogeneic mouse combination when antigen pre-exposure and CD40-CD40 ligand antibody blockage are employed. A human trial in patients with resistant neoplasia infusing pheresed blood with 108 CD3 cells/kg showed that tumor responses and complete chimerism occur with very low levels of CD34+ cells/kg and that the extent of previous treatment is a critical factor in determining chimerism. A major feature of transplants is the phenotype of the donor stem cell. This phenotype shows dramatic reversible plasticity involving differentiation, adhesion protein expression, and engraftment with cytokine-induced cell-cycle transit. Homing is probably also plastic. Marked fluctuations in engraftment capacity are also seen at different points in marrow circadian rhythm.",
keywords = "Circadian rhythm, Engraftment, Myeloablation, Plasticity, Stem cell",
author = "Quesenberry, {P. J.} and Stewart, {F. M.} and P. Becker and Lionel D'Hondt and A. Frimberger and Lambert, {J. F.} and Colvin, {G. A.} and C. Miller and C. Heyes and Mehrdad Abedi and M. Dooner and J. Carlson and J. Reilly and C. McAuliffe and K. Stencel and K. Ballen and R. Emmons and P. Doyle and S. Zhong and H. Wang and H. Habibian",
year = "2001",
language = "English (US)",
volume = "938",
pages = "54--62",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Stem cell engraftment strategies

AU - Quesenberry, P. J.

AU - Stewart, F. M.

AU - Becker, P.

AU - D'Hondt, Lionel

AU - Frimberger, A.

AU - Lambert, J. F.

AU - Colvin, G. A.

AU - Miller, C.

AU - Heyes, C.

AU - Abedi, Mehrdad

AU - Dooner, M.

AU - Carlson, J.

AU - Reilly, J.

AU - McAuliffe, C.

AU - Stencel, K.

AU - Ballen, K.

AU - Emmons, R.

AU - Doyle, P.

AU - Zhong, S.

AU - Wang, H.

AU - Habibian, H.

PY - 2001

Y1 - 2001

N2 - The donor stem cell phenotype and host microenvironment determine the outcome of a stem cell transplant. In a series of transplant studies in syngeneic male to female or congenic Ly5.1/Ly5.2 models in which hosts have received no or minimal irradiation (100 cGy), evidence overwhelmingly supports the concept that syngeneic engraftment is determined by stem cell competition. These approaches can be extended to H-2 mismatched allogeneic mouse combination when antigen pre-exposure and CD40-CD40 ligand antibody blockage are employed. A human trial in patients with resistant neoplasia infusing pheresed blood with 108 CD3 cells/kg showed that tumor responses and complete chimerism occur with very low levels of CD34+ cells/kg and that the extent of previous treatment is a critical factor in determining chimerism. A major feature of transplants is the phenotype of the donor stem cell. This phenotype shows dramatic reversible plasticity involving differentiation, adhesion protein expression, and engraftment with cytokine-induced cell-cycle transit. Homing is probably also plastic. Marked fluctuations in engraftment capacity are also seen at different points in marrow circadian rhythm.

AB - The donor stem cell phenotype and host microenvironment determine the outcome of a stem cell transplant. In a series of transplant studies in syngeneic male to female or congenic Ly5.1/Ly5.2 models in which hosts have received no or minimal irradiation (100 cGy), evidence overwhelmingly supports the concept that syngeneic engraftment is determined by stem cell competition. These approaches can be extended to H-2 mismatched allogeneic mouse combination when antigen pre-exposure and CD40-CD40 ligand antibody blockage are employed. A human trial in patients with resistant neoplasia infusing pheresed blood with 108 CD3 cells/kg showed that tumor responses and complete chimerism occur with very low levels of CD34+ cells/kg and that the extent of previous treatment is a critical factor in determining chimerism. A major feature of transplants is the phenotype of the donor stem cell. This phenotype shows dramatic reversible plasticity involving differentiation, adhesion protein expression, and engraftment with cytokine-induced cell-cycle transit. Homing is probably also plastic. Marked fluctuations in engraftment capacity are also seen at different points in marrow circadian rhythm.

KW - Circadian rhythm

KW - Engraftment

KW - Myeloablation

KW - Plasticity

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=0034931365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034931365&partnerID=8YFLogxK

M3 - Article

C2 - 11458526

AN - SCOPUS:0034931365

VL - 938

SP - 54

EP - 62

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -